Blinatumomab and Its Role in Pediatric Leukemia

Tuesday, June 4, 2024, 8:00 AM - 9:00 AM, Marlo Thomas Center Lecture Hall, Memphis, TN

The purpose of the LLH/BMTCT Conference is to update knowledge related to the diagnosis and treatment of pediatric malignant and benign hematologic diagnoses, bone marrow transplantation and  cellular therapies; promote interaction among health care providers, research staff and clinical investigators; and use case presentation followed by literature review and open plenary discussion to improve audience members' performance in an education setting.

Objective(s): 1 Describe the history and development of blinatumomab for managing B-cell lymphoblastic leukemia and lymphoma. Review studies evaluating the efficacy and safet 2 Review studies evaluating the efficacy and safety of Blinatumomab in pediatric B-cell acute lymphoblastic leukemia. 3 Explain the concept of T-cell exhaustion during treatment with Blinatumomab.
Location: Marlo Thomas Center Lecture Hall
Specialties: Hematology, Oncology, Pediatrics, Pharmaceutical Sciences, Palliative Care, Infectious Diseases, Bone Marrow Transplant/Cellular Therapy, Immunology, Pharmaceutical Services, Global Pediatric Medicine

Faculty Disclosures:
Benjamin A Youngblood, PhD (Honoraria-Genentech (Relationship has ended) - 05/31/2024)
Marleni R Torres Nunez, MD (Nothing to disclose - 07/17/2023)
Download Handout

1. Describe the history and development of blinatumomab for managing B-cell lymphoblastic leukemia and lymphoma. Review studies evaluating the efficacy and safet
2. Review studies evaluating the efficacy and safety of Blinatumomab in pediatric B-cell acute lymphoblastic leukemia.
3. Explain the concept of T-cell exhaustion during treatment with Blinatumomab.

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.